Bristol-Myers beats Wall St estimates, helped by cancer drug Opdivo

NEW YORK (Reuters) - Bristol-Myers Squibb Co on Thursday reported higher-than-expected quarterly earnings, helped by increased sales of cancer drugs Opdivo and Yervoy and blood thinner Eliquis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news